These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18765694)

  • 1. In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.
    Fernandes Rodrigues JC; Concepcion JL; Rodrigues C; Caldera A; Urbina JA; de Souza W
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4098-114. PubMed ID: 18765694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.
    de Macedo-Silva ST; Visbal G; Urbina JA; de Souza W; Rodrigues JC
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6402-18. PubMed ID: 26239973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
    Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis.
    Rodrigues JC; Urbina JA; de Souza W
    Exp Parasitol; 2005 Dec; 111(4):230-8. PubMed ID: 16198340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi.
    Urbina JA; Concepcion JL; Caldera A; Payares G; Sanoja C; Otomo T; Hiyoshi H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2379-87. PubMed ID: 15215084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two squalene synthase inhibitors, E5700 and ER-119884, interfere with cellular proliferation and induce ultrastructural and lipid profile alterations in a Candida tropicalis strain resistant to fluconazole, itraconazole, and amphotericin B.
    Ishida K; Visbal G; Rodrigues JC; Urbina JA; de Souza W; Rozental S
    J Infect Chemother; 2011 Aug; 17(4):563-70. PubMed ID: 21264486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.
    de Macedo-Silva ST; Urbina JA; de Souza W; Rodrigues JC
    PLoS One; 2013; 8(12):e83247. PubMed ID: 24376670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzylamines as highly potent inhibitors of the sterol biosynthesis pathway in Leishmania amazonensis leading to oxidative stress and ultrastructural alterations.
    de Macedo-Silva ST; Visbal G; Souza GF; Dos Santos MR; Cämmerer SB; de Souza W; Rodrigues JCF
    Sci Rep; 2022 Jul; 12(1):11313. PubMed ID: 35788652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel alkyl phosphocholine-dinitroaniline hybrid molecule exhibits biological activity in vitro against Leishmania amazonensis.
    Godinho JL; Georgikopoulou K; Calogeropoulou T; de Souza W; Rodrigues JC
    Exp Parasitol; 2013 Sep; 135(1):153-65. PubMed ID: 23845259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
    Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
    PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis.
    Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S
    Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
    Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
    Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squalene synthase as a target for Chagas disease therapeutics.
    Shang N; Li Q; Ko TP; Chan HC; Li J; Zheng Y; Huang CH; Ren F; Chen CC; Zhu Z; Galizzi M; Li ZH; Rodrigues-Poveda CA; Gonzalez-Pacanowska D; Veiga-Santos P; de Carvalho TM; de Souza W; Urbina JA; Wang AH; Docampo R; Li K; Liu YL; Oldfield E; Guo RT
    PLoS Pathog; 2014 May; 10(5):e1004114. PubMed ID: 24789335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-butyl-[1-(4-methoxy)phenyl-9H-β-carboline]-3-carboxamide prevents cytokinesis in Leishmania amazonensis.
    Stefanello TF; Panice MR; Ueda-Nakamura T; Sarragiotto MH; Auzély-Velty R; Nakamura CV
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7112-20. PubMed ID: 25224005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania amazonensis: Increase in ecto-ATPase activity and parasite burden of vinblastine-resistant protozoa.
    Giarola NL; Silveira TS; Inacio JD; Vieira LP; Almeida-Amaral EE; Meyer-Fernandes JR
    Exp Parasitol; 2014 Nov; 146():25-33. PubMed ID: 25176449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors.
    Granthon AC; Braga MV; Rodrigues JC; Cammerer S; Lorente SO; Gilbert IH; Urbina JA; de Souza W
    Vet Parasitol; 2007 May; 146(1-2):25-34. PubMed ID: 17367936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
    Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.